RNF43: A Biomarker With Potential Ramifications for Therapeutic Intervention in Gastric Cancer.
Division of Gastroenterology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
Division of Gastroenterology, Department of Medicine, Vanderbilt University Medical Center, Department of Pathology, Microbiology, and Immunology, Vanderbilt University, Nashville, Tennessee. Electronic address: [email protected]
- Published Article
Cellular and Molecular Gastroenterology and Hepatology
- Publication Date
Dec 19, 2020
Report this publication
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
This record was last updated on 02/22/2021 and may not reflect the most current and accurate biomedical/scientific data available from NLM.
The corresponding record at NLM can be accessed at https://www.ncbi.nlm.nih.gov/pubmed/33347817